RANDOMISATION in Croatian translation

• randomizacija
• randomizacije
• randomizaciji

Examples of using Randomisation in English and their translations into Croatian

regardless of their previous randomisation.
bez obzira na njihovu prethodnu randomizaciju.

At randomisation, these patients consumed such a small amount of alcohol that there was little room for further improvement floor effect.
Ovi su bolesnici u trenutku randomizacije konzumirali toliko male količine alkohola da je bilo malo mjesta za daljnja poboljšanja floor effect.

Proportions of Subjects in the Once Daily versus Twice Daily Abacavir+Lamivudine Randomisation of ARROW with Plasma HIV-1 RNA< 80 copies/ml: Subgroup Analysis by Formulation.
Udio ispitanika s HIV-1 RNK u plazmi< 80 kopija/ml nakon randomizacije za primjenu abakavira+ lamivudina jedanput na dan naspram dvaput na dan u ispitivanju ARROW: analiza podskupina prema formulaciji lijeka.

Randomisation was stratified by screening HIV-1 RNA level≤ 100,000 copies/ml or> 100,000 copies/ml.
Randomozacija je stratificirana probiranjem na razinu HIV-1 RNK ≤ 100 000 kopija/ml ili> 100 000 kopija/ml.

Randomisation was stratified by sites of disease
Bolesnice su randomizirane prema sijelu bolesti

The difference in results between these randomisation subgroups may have arisen by chance in view of their limited sample size.
S obzirom na mali uzorak, razlika u rezultatima između ovih randomizacijskih podskupina mogla je nastati slučajno.

very high DRL at randomisation were defined post hoc as the target population.
vrlo visok RPP u trenutku randomizacije post hoc definirani kao ciljana populacija.

The primary outcome was a composite of peri-PCI(defined as time of randomisation up to 48 hours post-PCI) adjudicated major
Primarni ishod ispitivanja je bio združeni parametar periproceduralnog(vrijeme definirano kao vrijeme od randomizacije do 48 sati nakon PCI)

Time to clinical worsening was a secondary endpoint as defined as the time from randomisation to the first occurrence of a clinical worsening event death,
Sekundarni ishod bilo je vrijeme do kliničkog pogoršanja, definirano kao vrijeme od randomizacije do prve pojave događaja kliničkog pogoršanja smrt,

Randomisation was stratified by PDGFR-α expression(positive versus negative), number of previous
Randomizacija je bila stratificirana prema ekspresiji PDGFR-α(pozitivan naspram negativnog nalaza),

significant abnormalities of liver function as well as those with significant physical withdrawal symptoms at screening or randomisation were excluded.
značajnim abnormalnostima funkcije jetre u anamnezi, kao i oni sa značajnim fizičkim simptomima ustezanja u vrijeme probira ili randomizacije bili su isključeni.

within 30 days of randomisation.
unutar 30 dana od randomizacije.

The improvement in the proportion of patients who achieved SVR was consistent across all subgroups in the randomisation strata baseline platelet counts(< 50,000 vs.>
Poboljšanje u udjelu bolesnika koji su postigli SVR bilo je konzistentno kroz sve podskupine u randomizacijskom stratumu početni broj trombocita(<

at 24 weeks after randomisation.
nakon 24 tjedna od randomizacije.

myocardial re-infarction in the first 30 days after randomisation, was 9.9% in the enoxaparin group, as compared to 12.0% in the unfractionated heparin group,
uključujući smrt ili reinfarkt miokarda unutar prvih 30 dana nakon randomizacije, iznosila je 9, 9% u skupini koja je primala enoksaparin, u usporedbi s

The recommendation on the loading dose in patients with UA/NSTEMI whose coronary angiography is carried out within 48 hours after hospitalisation is based on the outcome of the recently completed ACCOAST clinical study in patients with NSTEMI that had to be subject to coronary angiography within 2 to 48 h after randomisation.
Preporuka o udarnoj dozi u bolesnika s UA/NSTEMI u kojih se koronarna angiografija provodi unutar 48 sati nakon primitka u bolnicu temelji se na ishodu nedavno dovršenog kliničkog ispitivanja ACCOAST u bolesnika s NSTEMI koji su trebali biti podvrgnuti koronarnoj angiografiji unutar 2 do 48 sati nakon randomizacije.

for example by use of a centralised electronic randomisation system, use of a centralised information system,
na primjer upotrebom centraliziranog elektronikog sustava randomizacije, upotrebom centraliziranog informacijskog sustava,

Progression-free survival. a Time from randomisation to progression or death due to any cause,
preživljenje bez progresije bolesti a Vrijeme od randomizacije do progresije bolesti ili smrti zbog bilo kojeg uzroka,

use of any diabetic treatment after randomisation, a fasting glucose≥126 mg/dL or a non-fasting glucose≥200 mg/dL after randomisation 18.3% vs 5.6%, p=0.025.
primjena bilo koje antidijabetičke terapije nakon randomizacije, s glukozom natašte ≥126 mg/dl ili glukozom mjerenom tijekom dana(bez 8-satnog neuzimanja hrane) od ≥200 mg/dl nakon randomizacije 18,3% naspram 5,6%, p=0.025.

for example by use of a centralised electronic randomisation system, use of a centralised information system,
na primjer upotrebom centraliziranog elektroničkog sustava randomizacije, upotrebom centraliziranog informacijskog sustava,